The Future of Fibrinolysis Agents
<p id="p1">Since the 1990s, the second-generation tissue plasminogen activator alteplase has been accepted as the gold standard in the thrombolysis of acute ischemic stroke, acute myocardial infarction, and pulmonary embolism. Alteplase, however, is not without its limitations, including a short hal...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2024
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/89634 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: The Future of Fibrinolysis Agents
- Comparative Fibrinolysis
- Type 2 Diabetes and Fibrinolysis
- Marine-Derived Novel Compounds for Fibrinolysis
- Coagulation and Fibrinolysis Abnormalities in Patients with Muscular Dystrophy
- S100A10: A Key Regulator of Fibrinolysis
- Fibrinolysis at the Interface of Thrombosis and Inflammation — The Role of Neutrophil Extracellular Traps